Recent Advances in the Treatment of Chronic GVHD: ASH 2024 - Episode 9

Future Perspectives and Key Takeaways

Panelists discuss the role of combination therapies in the management of graft-vs-host disease (GVHD), exploring the potential benefits and challenges of using multiple agents concurrently to improve treatment outcomes and manage complications.

EP. 1: Understanding Graft-VS-Host Disease (GVHD) Basics
EP. 2: Early Diagnosis and Intervention in GVHD Part 1
EP. 3: Early Diagnosis and Intervention in GVHD Part 2
EP. 4: Managing Skin Manifestations and Organ Involvement in GVHD
EP. 5: Treatment Decision-Making in Chronic GVHD
EP. 6: NCCN Guidelines and Clinical Updates in Chronic GVHD
EP. 7: FDA-Approved Therapies for Chronic GVHD
EP. 8: Challenges, Limitations, and Treatment Sequencing in Chronic GVHD
Now Viewing
EP. 9: Future Perspectives and Key Takeaways

Video content above is prompted by the following:

Can you discuss the role of combination therapies in the management of GVHD? What are the potential benefits and challenges of using multiple agents concurrently?